🔥 Jobs in Women's Health December 16, 2025

Hi there,

Welcome to Issue #124!

⬇️ This weeks highlights! ⬇️

• 5 Real-World Lessons on Scaling Women’s Health Companies— Practical insights from a women’s health founder on what it really takes to scale safely, efficiently, and successfully.

• New Science, Funding, and Policies in Women’s Health— Here are three stories worth paying attention to, and why they matter.

• Upcoming Events—Check out our upcoming events The Future of Menopause in 2035 and Building a 10-Step Plan for Your Career in Women’s Health.

• Women’s Health Jobs — Exclusive role at Mae and over 100 new women’s health positions listed this past week.

Thanks for being here.  Let’s keep building the future of health — together.  

If this email gets clipped, select VIEW ENTIRE MESSAGE at the bottom.

📧 Was this forwarded to you? Subscribe free here.

10 Lessons on Building, Leading, and Scaling in Women’s Health

From Monica Cepak, CEO of Wisp

There are founders who talk about scale and then there are founders who quietly build the systems that make scale inevitable.

This week, as part of the In Women’s Health Mini-MBA, we sat down with Monica Cepak, CEO of Wisp, one of the most operationally disciplined, clinically rigorous, and capital-efficient companies I know in women’s health.

What stood out wasn’t just what Wisp has built, but how Monica thinks about governance, speed, and trust when you’re building in a regulated market where real patient safety and outcomes are on the line.

Even as a seasoned Founder, I learned a ton and wanted to share it with you. Below are 10 lessons I took away from Monica that every operator, founder, and investor in women’s health should internalize grounded in real examples she shared.

1. Speed is not recklessness when governance is strong

Monica described how Wisp can move quickly because clinical decision-making is structured. When new research or a customer need surfaces, the business doesn’t “decide” clinically what to do; it triggers a clinical process which leads to decision making. 

She shared how Wisp has, at times, been able to turn new research into patient-ready offerings in a matter of weeks, a huge competitive advantage in the categories they operate in. What makes that speed safe is the rigor behind it: a clinical advisory function that owns protocols, approvals, and guardrails.

Takeaway: Speed can be a competitive advantage but only when the right clinical protocols and governance structures are already in place.

2. Clinical independence is not optional—it’s foundational

One of Monica’s strongest points was how clinical authority cannot be a marketing layer. Clinical partners must have real decision-making power.

She explained that Wisp is built to “lead with a clinical voice,” and that this isn’t a brand choice, it’s how trust is earned and downstream risk is reduced. She also shared that there are moments when clinical leaders make decisions that aren’t ideal for the business in the short term and as CEO, her role is to stand behind those calls.

Takeaway: If clinical leaders don’t have real decision-making power, your trust and your business will eventually erode.

3. Corporate structure matters more than most people realize

Monica walked through a nuance many consumers miss: patients assume they’re “getting care from Wisp,” but Corporate Practice of Medicine laws require the separation of clinical and business entities.

Her point wasn’t legal trivia, it’s an important distinction.  We probably need to be more clear about this with consumers. The structure reinforces that the business side runs marketing, technology, and support, while clinical leaders run care decisions. That separation is what allows companies to scale without compromising trust.

Takeaway: Structural separation through legal regulation isn’t bureaucracy, it’s how healthcare companies scale safely.

4. Trust is built in the unglamorous work: claims review and marketing governance

Monica shared how seriously Wisp takes marketing claims review, not as compliance theater, but as an important part of their brand protection.

Clinical teams review marketing claims, landing pages, and marketing assets because once credibility is lost, the growth engine collapses. This rigor allows Wisp to move fast publicly without taking hidden risks.

Takeaway: The most durable brands invest heavily in invisible rigor that saves time in the long run. 

5. Capital efficiency forces better decisions—especially under pressure

Wisp has taken on a relatively small amount of outside capital. As a result, Monica shared how the company has had to operate with deep fiscal discipline and how that constraint has made them stronger.

She contrasted this with companies that raise large VC rounds and feel pressure to spend, hire, and expand prematurely often creating complexity they can’t unwind later.

Takeaway: Capital discipline sharpens judgment; excess capital often dulls it.

6. Don’t buy the myth that you need a perfect brand to win

Monica was candid that Wisp didn’t over-invest in brand early. Instead, the company focused on product-market fit, patient experience, and fundamentals.

She’s seen founders spend $50K–$100K on branding before they understand what truly resonates, and then they wonder why growth stalls.

Takeaway: A strong brand amplifies product-market fit, it can’t replace it.  Start with the product-market fit. 

7. Your unit economics should dictate your marketing strategy—not ego

Monica shared how Wisp approaches marketing as a system. Acquisition strategy varies by category because LTV and CAC differ by product and patient need.

She also described their rigorous data discipline around marketing.  They monitor performance and data closely and adjust budgets in near real time when needed.

Takeaway: Marketing discipline is a finance function, not a creative preference.

8. The best leaders know when to build vs. partner

Monica outlined how Wisp makes build-vs-partner decisions using a real internal analysis: cost to build, operational complexity, timeline, risk, and expected ROI.

In one case, the conclusion was clear: building would be slower, riskier, and distract from higher-priority bets. Partnering wasn’t retreat, it was focus for them and an important part of their competitive moat around speed. 

Takeaway: Strategic restraint is often a sign of strong leadership, not weakness.

9. Patients will pay for speed and clarity—if you deliver on the promise

Monica explained Wisp’s model simply: in urgent, high-discomfort moments, patients don’t want to wait days navigating the traditional system.

But speed only matters if it’s real. She was clear about holding the company accountable to service-level promises rather than stretching the truth in marketing.  Negotiating these service-level agreements and then holding their partners to them have been an important part of their competitive advantage.  

Takeaway: Trust is operational and once broken, it’s expensive to rebuild with consumers.

10. If you want to work in women’s health, prove you can operate in complexity

When hiring, Monica doesn’t default to healthcare background. She looks for people who can navigate regulated, ambiguous environments, make sound decisions in gray zones, and stay solution-oriented.

She also noted that people from very large organizations don’t always thrive at Wisp, not due to lack of talent, but because Wisp requires ownership, speed, and comfort with uncertainty.

If you’re interviewing with Wisp, or a company like them, and come from a large organization, how can you demonstrate in the interview process how you can operate in ambiguous environments?  

Takeaway:To build a career in women’s health, you have to show—through examples—that you can change direction quickly, operate without perfect information, and prioritize shipping over perfection when the moment demands it.

The Bigger Insight

What makes Monica’s approach stand out is that she’s not optimizing for optics,  she’s optimizing for repeatable systems, and it’s working.  She’s focused on: 

• clinical governance that protects trust

• operational and fiscal discipline that protects cash

• growth strategy grounded in economics and real-time data

In women’s health, where the stakes are real and the scrutiny is high, that combination is a moat.

As we head into the new year, one thing is becoming increasingly clear:
women’s health is no longer a niche or emerging sector—it is a serious, competitive, and rapidly professionalizing market.

Capital is consolidating. Teams are leaner. Roles are more specialized. And while interest in women’s health continues to surge, getting hired has quietly become more difficult.

Most professionals don’t struggle because they lack experience or commitment.
They struggle because they haven’t been taught how to translate their background into language that resonates with founders, operators, and investors—or how to navigate a hiring process that is deeply relationship-driven and unlike traditional tech or healthcare recruiting.

The In Women’s Health Career Mastermind was built to address exactly that gap.

This four-week, high-touch experience is designed for people who want to enter—or advance within—women’s health with intention. The focus is not on job boards or surface-level tactics, but on the mechanics that actually drive outcomes: positioning, narrative, signal-building, and access.

Our January 20th cohort reflects how the market is evolving. We’ve expanded live sessions to allow for deeper coaching and added weekly progress check-ins to help participants maintain momentum and clarity as they do the work.

Inside the Mastermind, participants focus on:

• Resume and LinkedIn positioning aligned with how women’s health companies actually evaluate talent

• Career narratives that are clear, credible, and compelling in interviews and founder conversations

• Practical frameworks for networking, outreach, and follow-through in a relationship-driven ecosystem

• Exposure to founders, recruiters, and operators actively building in the space

• A private, global peer network that continues well beyond the four-week program

The goal isn’t simply to help you land a role.
It’s to help you be legible to the market—to understand where you fit, how to articulate your value, and how to move strategically when the right opportunity emerges.

If you’re curious what this work actually looks like in practice, Friday’s “10 Steps to Get a Job in Women’s Health” webinar (12/10) offers a clear preview. The session walks through the foundational thinking, frameworks, and common pitfalls that the Career Mastermind builds on in much greater depth.

For many participants, the webinar is a useful way to assess whether the Mastermind is the right next step before committing.

Women’s health roles now regularly attract hundreds—sometimes thousands—of applicants. In 2025, the differentiator will not be enthusiasm alone, but clarity, positioning, and execution.

The January 20th Career Mastermind cohort is intentionally small, with limited remaining seats.

🔥 Why now? Every top women’s health job gets over 1,000 applicants within 48 hours.
his isn’t about luck—it’s about knowing exactly how to stand out.

Join the only program built by leaders in the industry, for those who want to get hired, grow faster, and make an impact that matters.

Want to secure 2025 pricing? Use Promo Code MM2025.

✨ Only 12 seats left available. 

This week In Women’s Health founder Jodi reached out on LinkedIn to hear from the community about who’s driving meaningful change in women’s health through nonprofit and public health work.

Responses are rolling in—here’s a preview of three organizations making a real impact:

1. Postpartum Support International
   Supports families dealing with perinatal mental health challenges, including postpartum depression and anxiety, through education, resources, and peer support.
   Website: https://www.postpartum.net

2. Tech4Fem – (Italy)
   Italy’s first nonprofit focused on advancing femtech and digital health solutions, improving access to women’s health technology and wellness tools worldwide.
   Website: https://tech4fem.org

3. Cherished Mom – (Tennessee, USA)
   Empowers pregnant and postpartum families in Tennessee with mental health education, peer support, and advocacy programs.
   Website: https://www.cherishedmom.org

Women’s Health Is Shifting Fast — Here Are 3 Changes You Should Know About

Women’s health is moving quickly right now. New science, new policies, and new funding rounds are reshaping what care looks like — from the medications being developed to the clinics women rely on every day.
Here are three stories worth paying attention to, and why they matter.

1. Primary-care access is shifting as Medicaid policy changes — here’s what to know

Several updates in Medicaid policy for 2025 are creating uncertainty for community health centers and women’s health clinics that rely heavily on Medicaid reimbursements. These changes vary by state, but many clinics are preparing for potential adjustments to how preventive and primary-care services are funded.

Some states are evaluating new rules around reimbursement rates, managed-care contracts, and reporting requirements. Others are navigating temporary federal guidance that is still being interpreted or challenged in court. The result is a landscape where clinics are trying to plan ahead without clear, long-term answers.

Why this matters:
For millions of women, Medicaid-funded clinics are where they receive Pap tests, birth control, STI testing, prenatal care, postpartum support, and chronic-condition management. When reimbursement rules change — or even might change — clinics sometimes pause hiring, shorten hours, or scale back programs until they know what funding will look like. That can translate into longer waits, fewer open appointment slots, and reduced access in rural or lower-income communities.

Where to learn more:
Search for your state's 2025 Medicaid updates, or look to national sources like the KFF Medicaid policy tracker and the Congressional Research Service (CRS) summaries for ongoing federal guidance.

2. Investors are pouring money into whole-life women’s mental health

Two major funding rounds signal a shift: women’s mental health — from pregnancy to menopause — is finally being treated as core health infrastructure.

• FamilyWell Health raised $8M (Series A) to scale its model that embeds mental-health support directly into OB-GYN and women’s-health clinics. They’re expanding beyond pregnancy/postpartum into perimenopause and menopause, backed by clinician training through the FamilyWell Academy.

• Diana Health raised $55M (Series C) to grow its network of women-centered clinics that partner with hospitals and offer longer visits plus integrated care — mental health, birth planning, education, and gynecologic services all under one roof.

Why this is worth watching:
Women’s mental health has long been fragmented — postpartum care here, menopause care there, therapy somewhere else. These models treat the whole picture: hormonal shifts, identity changes, parenting stress, and menopause transitions as connected, not isolated events. Investors betting big here means more integrated clinics and virtual support could become the norm.

3. Vaginal health is finally getting the R&D spotlight it deserves

A major new research call — led by the Science for Africa Foundation and its global partners — is putting vaginal health front and center. The initiative, Accelerating Innovation in Vaginal Formulations in Support of Women’s Health, is looking for next-generation products that are actually designed with women’s real lives in mind: comfort, cultural context, privacy, and biological relevance. It’s especially focused on innovations that could make a difference in low- and middle-income countries.

Why this is a big deal:
The vagina is an incredibly effective drug-delivery route, but it’s been underfunded and understudied. New formulations could help prevent STIs, deliver medications locally with fewer side effects, and open the door to more self-managed care options. And because this call is African-led, researchers and women from Nairobi, Lagos, and Johannesburg are helping shape what gets built — not just labs in New York or London.

Want to explore the full RFP?
Science for Africa Foundation: Accelerating Innovation in Vaginal Formulations…

The bottom line

Across R&D, policy, and care delivery, women’s health is in a moment of real change:

• Science is shifting toward user-centered, globally relevant innovation.

• Policy fights are shaping access to basic reproductive and preventive care.

• Investment is moving toward integrated, whole-life mental-health models.

If these trends continue, the next few years could look very different — and much better — for how women receive care.

📆 Upcoming In Women’s Health Events

Planning to attend HERS next March? Check out the full agenda—including Jodi Neuhauser’s panels on women’s health innovation—here!

✨ Now … let’s make your career magic happen

Featured Roles:

___________________

Julia Cheek is the founder and CEO of Everly Health, the parent company of Everlywell. She launched the company in 2015 to give people more affordable and convenient access to lab testing without long waits or traditional doctor visits, drawing on her own experience navigating costly, confusing health testing. Under her leadership, Everlywell has grown into a major digital health brand and helped expand at‑home testing options for millions of people.

Everlywell is a digital health company based in Austin, Texas, best known for its at‑home lab testing kits that let consumers collect samples at home and get physician‑reviewed results online. Since its founding in 2015, the company has expanded beyond core women’s and hormone tests to offer dozens of health panels — from fertility and thyroid to food sensitivity and wellness markers — and has raised significant venture funding as part of its growth.

📌 Principal Product Manager - Patient Experience

___________________

David Stern is the CEO of Kindbody, appointed in mid-2025 to lead the company through its next phase of growth and operational scale. He brings deep experience in healthcare leadership and transformation, with a focus on building sustainable, patient-centered care models. At Kindbody, Stern is focused on strengthening the company’s integrated fertility and family-building platform for employers, patients, and clinicians.

Kindbody is a national fertility and women’s health company offering in-clinic and virtual services, from fertility assessments to IVF, egg freezing, and holistic care. Founded by Bartasi in 2018, it partners with employers and operates clinics across the U.S. to make reproductive care more accessible and patient-friendly.

📌 Practice Coordinator

___________________

OrderlyMeds is a pioneering Medical Weight Loss telemedicine platform focused on making healthcare simple, personalized, and human. The company combines GLP-1 medication with holistic support in mental health, fitness, and nutrition, creating a fully integrated wellness experience. Powered by a custom Large Language Model (LLM) that acts as a personal healthcare assistant, OrderlyMeds delivers tailored guidance to help individuals achieve sustainable, transformative health goals.

📌 Director of Strategic Partnerships

International:

Senior Backend Engineer - Martech Integrations, Flo Health (Menstruation, Series B), Vilnius, Lithuania.

Frontend Engineer, Sword Health, Porto, Portugal.

Strategy & Ops Associate, Sword Health, Lisbon, Portugal.

Business (Ops/Strategy/Legal/Quality & Regulatory & HR

Strategic Account Executive, Carrot Fertility (Fertility, Series B), Remote, $153K - $200K.

People Operations Associate, Pomelo Care (Maternal Health, Series A), New York, NY, $70K - $85K.

Senior People Partner, Tia (Clinical Care, Series B), Los Angeles, CA, $130K-$145K.

Director, Client Success, Progyny (Fertility, Public), Missouri, MO · New York, NY · Remote, $140K - $155K.

Manager, R&D Laboratory Operations, Natera (Lab Testing, Public), San Carlos, CA, $109,700—$137,200.

Sr Product Manager, Conversational AI & Voice Automation, Natera (Lab Testing, Public), United States · Remote, $120,100—$150,100.

Manager, Software Engineering, Natera (Lab Testing, Public), United States · Remote, $129,400—$161,800.

Temporary Merchandise Planner I, Babylist (Parenting, Series C), United States, $43.39 - $49.81/hr.

Global Payments Operations Specialist, Carrot Fertility (Fertility, Series B), Remote, $70K - $88K.

PSC Manager- Nashville, TN, Natera (Lab Testing, Public), Nashville, TN.

Clinic Authorization Specialist, Progyny (Fertility, Public), New York, NY· Remote, $28 - $31.25/hr.

Customer Success Director, Pomelo Care (Maternal Health, Series A), United States, $160K-$190K.

Customer Success Manager, Pomelo Care (Maternal Health, Series A), United States, $100K-$125K.

Clinical Program Success Manager, New Ventures, Pomelo Care (Maternal Health, Series A), United States, $95K-$110K.

Billing Specialist, Mae (Maternal Health, Seed), New York, NY, $58,000 - $62,500.

Quality Systems Manager, Bobbie (Parenthood, Series C), Heath, OH, $140K - $150K. 

Product/Engineering/Data & Analytics

Senior Analyst, Strategic Finance, Pomelo Care (Maternal Health, Series A), United States, $100K-$130K.

Software Engineer, UI, Natera (Lab Testing, Public), United States · Remote, $125,600—$157,000.

Software Engineer, Full Stack (Sr./SWE3), Natera (Lab Testing, Public), United States · Remote, $102,400—$128,000.

Analyst, Corporate Strategy, Hims & Hers (Digital Health, Public), United States · Remote, $100K – $120K.

Senior and C-Level Roles

VP, E-Commerce & Media Strategy, Frida (Parenthood, Private Equity), Miami, FL.

Head of Marketing, Sword Health, United States.

Clinical Roles & In-Clinic Business Roles

VA- IVF Nurse Coordinator, CCRM Fertility (Fertility, Private Equity), Vienna, VA, $35 - $45/hr.

CO- Molecular Genetic Scientist, CCRM Fertility (Fertility, Private Equity), Lone Tree, CO, $32 - $38/hr.

CO- IVF Nurse Coordinator, CCRM Fertility (Fertility, Private Equity), Lone Tree, CO, $38 - $44/hr.

TX- Clinical Coordination Assistant, CCRM Fertility (Fertility, Private Equity), Houston, TX, $20 - $24/hr.

TN- Medical Assistant (Full-time), Diana Health, Smyrna, TN.

TN- Patient Representative (Part-Time), Diana Health, Smyrna, TN.

TN- Practice Manager (Full-time), Diana Health, Smyrna, TN.

CA- Phlebotomist (Full-Time) - Culver City, Tia (Clinical Care, Series B), Culver City, CA.

Patient Benefits Coordinator, CCRM Fertility (Fertility, Private Equity), Remote, US, $20 - $27/hr. 

Peri/Menopause RN, Pomelo Care (Maternal Health, Series A), United States, $78K-$83K.

Obstetrics Triage RN - Weekend Focus (Sat, Sun & Flex Day), Pomelo Care (Maternal Health, Series A), United States, $75K-$83K.

Evening Perinatal Nurse - (5p-12a EST), Pomelo Care (Maternal Health, Series A), United States, $78K-$83K.

Note: This newsletter is for informational purposes only. For any legal questions or issues, please consult outside legal counsel. Any opinions expressed in this newsletter are solely my own and do not necessarily reflect those of my employer. I cannot guarantee the credibility of the sources or job listings I share. It's advisable to do your own research before engaging with them.

**********************************************************************